Drugs / adult donor RBC concentrates
adult donor RBC concentrates
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT05100212 Comparator | Dec 2021 → Jan 2025 | retinopathy of prematurity | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | adult donor RBC concentrates | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05100212 ↗ |
| Known as | A-RBCs | “transfusing HbF-enriched cord blood-red blood cells (CB-RBCs) instead of adult donor-RBC units (A-RBCs) reduces the incidence of severe ROP” PMID 39113069 ↗ Aug 2024 |
| Known as | adult-RBCs | “standard RBC transfusions (adult-RBCs) (control arm)” PMID 36514106 ↗ Dec 2022 |